van der Veur E, ten Berge B S, Donker A J, May J F, Schuurman F H, Wesseling H
Eur J Clin Pharmacol. 1985;28(3):351-2. doi: 10.1007/BF00543336.
After screening a local population in the northern part of The Netherlands for hypertension, 59 patients with a diastolic pressure (DP) between 95 and 130 mmHg were randomized and treated either with 50 mg atenolol (n = 29) or 100 mg atenolol (n = 30) for 1 month. There was no significant difference between the two treatments, neither in the fall in systolic and diastolic pressures nor in the number of complaints reported. It is concluded that in the initial treatment of uncomplicated mild to moderate hypertension, 100 mg atenolol has no advantage over a 50 mg dose.
在荷兰北部对当地人群进行高血压筛查后,将59名舒张压(DP)在95至130 mmHg之间的患者随机分组,分别给予50 mg阿替洛尔(n = 29)或100 mg阿替洛尔(n = 30)治疗1个月。两种治疗方法在收缩压和舒张压下降幅度以及报告的不适症状数量方面均无显著差异。得出的结论是,在单纯性轻至中度高血压的初始治疗中,100 mg阿替洛尔并不比50 mg剂量更具优势。